浅谈我国结核病与糖尿病共病治疗管理现状

doi:10.3969/j.issn.1000-6621.2021.01.005

中国防痨杂志 ›› 2021, Vol. 43 ›› Issue (1): 23-25.doi: 10.3969/j.issn.1000-6621.2021.01.005

浅谈我国结核病与糖尿病共病治疗管理现状

邓国防, 成诗明()

518112 国家感染性疾病临床医学研究中心深圳市第三人民医院肺病二科(邓国防);中国防痨协会(成诗明)

收稿日期:2020-11-30 出版日期:2021-01-10 发布日期:2021-01-12
通信作者: 成诗明 E-mail:smcheng@163.com
基金资助:
“十三五”国家科技重大专项(2018ZX10715004-002-012)

Received:2020-11-30 Online:2021-01-10 Published:2021-01-12

摘要/Abstract

邓国防, 成诗明. 浅谈我国结核病与糖尿病共病治疗管理现状[J]. 中国防痨杂志, 2021, 43(1): 23-25. doi: 10.3969/j.issn.1000-6621.2021.01.005

参考文献 15

[1]	World Health Organization. Global tuberculosis report 2020. Geneva: World Health Organization, 2020.
[2]	Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol, 2018,14(2):88-98. doi: 10.1038/nrendo.2017.151. doi: 10.1038/nrendo.2017.151 URL pmid: 29219149
[3]	World Health Organization. Guidelines for treatment of drug-susceptible tuberculosis and patient care, 2017 update. Geneva: World Health Organization, 2017.
[4]	Lin Y, Harries AD, Kumar AMV, et al. Management of diabetes mellitus-tuberculosis: a guide to the essential practice. Paris: International Union Against Tuberculosis and Lung Disease, World Diabetes Foundation, 2019.
[5]	Atif M, Sulaiman SA, Shafie AA, et al. Duration of treatment in pulmonary tuberculosis: are international guidelines on the management of tuberculosis missing something? Public Health, 2015,129(6):777-782. doi: 10.1016/j.puhe.2015.04.010. doi: 10.1016/j.puhe.2015.04.010 URL pmid: 25999175
[6]	唐神结, 高文. 临床结核病学. 北京: 人民卫生出版社, 2019.
[7]	Wang JY, Lee MC, Shu CC, et al. Optimal duration of anti-TB treatment in patients with diabetes: nine or six months? Chest, 2015,147(2):520-528. doi: 10.1378/chest.14-0918. doi: 10.1378/chest.14-0918 URL pmid: 25255302
[8]	World Health Organization. WHO consolidated guidelines on tuberculosis. Module 4: treatment- drug-resistant tuberculosis treatment. Geneva: World Health Organization, 2020.
[9]	中国防痨协会. 耐药结核病化学治疗指南(2019年简版). 中国防痨杂志, 2019,41(10):1025-1073. doi: 10.3969/j.issn.1000-6621.2019.10.001.
[10]	中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版). 中华糖尿病杂志, 2018,10(1):4-67. doi: 10.3760/cma.j.issn.1674-5809.2018.01.002.
[11]	杨俊朋, 宋君, 侯新国, 等. 预混胰岛素转换为甘精胰岛素联合口服降糖药有效性与安全性的观察. 中国糖尿病杂志, 2013,21(2):160-162. doi: 10.3969/j.issn.1006-6187.2013.02.019.
[12]	中华人民共和国卫生与计划生育委员会. 肺结核患者健康管理服务规范. 国卫办基层函〔2015〕880号. 2015-10-27.
[13]	周倩. 多学科团队管理对肺结核合并糖尿病病人生活质量的影响. 护理研究, 2013,27(33):3815-3816. doi: 10.3969/j.issn.1009-6493.2013.33.056.
[14]	Huangfu P, Ugarte-Gil C, Golub J, et al. The effects of diabetes on tuberculosis treatment outcomes: an updated systematic review and meta-analysis. Int J Tuberc Lung Dis, 2019,23(7):783-796. doi: 10.5588/ijtld.18.0433. doi: 10.5588/ijtld.18.0433 URL pmid: 31439109
[15]	Critchley JA, Restrepo BI, Ronacher K, et al. Defining a Research Agenda to Address the Converging Epidemics of Tuberculosis and Diabetes: Part 1: Epidemiology and Clinical Management. Chest, 2017,152(1):165-173. doi: 10.1016/j.chest.2017.04.155. doi: 10.1016/j.chest.2017.04.155 URL pmid: 28434936

浅谈我国结核病与糖尿病共病治疗管理现状

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 15

相关文章 0

编辑推荐

Metrics

本文评价

友情链接